Infectious diseases are a major cause of death and economic loss in animals. Most infections affect or are initiated at mucosal surfaces. Mucosal administration of a vaccine can effectively induce a protective immune response to protect animal populations.
Customized configurations of our VersiDoser® and VRx2™ delivery systems offer a non-invasive solution for improving efficacy, safety and simplifying administration of protective countermeasures to animal populations. Routes of non-invasive mucosal administration can include: nasal, ocular, genital, rectal and dermal. Our intelligent delivery systems facilitate compliance tracking of mass vaccination campaigns in large herds and eliminate the risks of needle based vaccine delivery.